These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37228393)

  • 41. The N
    Li B; Zhao R; Qiu W; Pan Z; Zhao S; Qi Y; Qiu J; Zhang S; Guo Q; Fan Y; Xu H; Li M; Li G; Xue H
    Theranostics; 2022; 12(14):6363-6379. PubMed ID: 36168628
    [No Abstract]   [Full Text] [Related]  

  • 42. The miR-429 suppresses proliferation and migration in glioblastoma cells and induces cell-cycle arrest and apoptosis via modulating several target genes of ERBB signaling pathway.
    Gheidari F; Arefian E; Saadatpour F; Kabiri M; Seyedjafari E; Teimoori-Toolabi L; Soleimani M
    Mol Biol Rep; 2022 Dec; 49(12):11855-11866. PubMed ID: 36219319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Midkine promotes glioblastoma progression via PI3K-Akt signaling.
    Hu B; Qin C; Li L; Wei L; Mo X; Fan H; Lei Y; Wei F; Zou D
    Cancer Cell Int; 2021 Sep; 21(1):509. PubMed ID: 34556138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular and Molecular Comparison of Glioblastoma Multiform Cell Lines.
    Demircan T; Yavuz M; Kaya E; Akgül S; Altuntaş E
    Cureus; 2021 Jun; 13(6):e16043. PubMed ID: 34345539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA‑543 inhibits proliferation, invasion and induces apoptosis of glioblastoma cells by directly targeting ADAM9.
    Ji T; Zhang X; Li W
    Mol Med Rep; 2017 Nov; 16(5):6419-6427. PubMed ID: 28849046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma.
    Saunders JT; Holmes B; Benavides-Serrato A; Kumar S; Nishimura RN; Gera J
    J Neurooncol; 2021 Apr; 152(2):217-231. PubMed ID: 33511508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. YY1-Activated Long Noncoding RNA SNHG5 Promotes Glioblastoma Cell Proliferation Through p38/MAPK Signaling Pathway.
    Chen L; Gong X; Huang M
    Cancer Biother Radiopharm; 2019 Nov; 34(9):589-596. PubMed ID: 31657621
    [No Abstract]   [Full Text] [Related]  

  • 48. Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway.
    Zhu M; Niu J; Jiang J; Dong T; Chen Y; Yang X; Liu P
    Life Sci; 2022 Mar; 293():120358. PubMed ID: 35092731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.
    Zhang G; Chen L; Khan AA; Li B; Gu B; Lin F; Su X; Yan J
    Int J Cancer; 2018 Aug; 143(3):635-644. PubMed ID: 29457830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TUSC3 suppresses glioblastoma development by inhibiting Akt signaling.
    Jiang Z; Guo M; Zhang X; Yao L; Shen J; Ma G; Liu L; Zhao L; Xie C; Liang H; Wang H; Zhu M; Hu L; Song Y; Shen H; Lin Z
    Tumour Biol; 2016 Sep; 37(9):12039-12047. PubMed ID: 27177902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BET bromodomain proteins are required for glioblastoma cell proliferation.
    Pastori C; Daniel M; Penas C; Volmar CH; Johnstone AL; Brothers SP; Graham RM; Allen B; Sarkaria JN; Komotar RJ; Wahlestedt C; Ayad NG
    Epigenetics; 2014 Apr; 9(4):611-20. PubMed ID: 24496381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care.
    Habib A; Pease M; Kodavali CV; Amankulor N; Zinn PO
    J Neurooncol; 2021 Jan; 151(2):103-112. PubMed ID: 33394264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.
    Xu Y; Stamenkovic I; Yu Q
    Cancer Res; 2010 Mar; 70(6):2455-64. PubMed ID: 20197461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression.
    Franceschi S; Corsinovi D; Lessi F; Tantillo E; Aretini P; Menicagli M; Scopelliti C; Civita P; Pasqualetti F; Naccarato AG; Ori M; Mazzanti CM
    EBioMedicine; 2018 Nov; 37():56-67. PubMed ID: 30314897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma.
    Walsh AM; Kapoor GS; Buonato JM; Mathew LK; Bi Y; Davuluri RV; Martinez-Lage M; Simon MC; O'Rourke DM; Lazzara MJ
    Mol Cancer Res; 2015 Aug; 13(8):1227-37. PubMed ID: 25934697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway.
    Ding X; Deng G; Liu J; Liu B; Yuan F; Yang X; Chen Q
    Brain Res; 2019 Aug; 1717():117-126. PubMed ID: 30935831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cucurbitacin B induces inhibitory effects via CIP2A/PP2A/Akt pathway in glioblastoma multiforme.
    Qin S; Li J; Si Y; He Z; Zhang T; Wang D; Liu X; Guo Y; Zhang L; Li S; Li Q; Liu Y
    Mol Carcinog; 2018 Jun; 57(6):687-699. PubMed ID: 29393542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance in human glioblastoma.
    Thanasupawat T; Glogowska A; Burg M; Krcek J; Beiko J; Pitz M; Zhang GJ; Hombach-Klonisch S; Klonisch T
    Mol Oncol; 2018 Sep; 12(9):1464-1479. PubMed ID: 29949238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR‑124 inhibits cell growth through targeting IQGAP1 in colorectal cancer.
    Fan J; Zhang W; Wu Y; Wan P; Guo Q; Zhang Y
    Mol Med Rep; 2018 Dec; 18(6):5270-5278. PubMed ID: 30272357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.